Linda Adlerz

Linda Adlerz has extensive work experience in the field of medical research and laboratory engineering. Linda is currently working as a Senior Scientist at iCellate Medical AB since June 2021. Prior to that, they held the position of Clinical Neuropathology Laboratory Engineer & Licensed Biomedical Scientist at Karolinska University Hospital from 2016 to 2021. At Karolinska, they designed and built a clinical neuropathology laboratory, created new methods, optimized traditional techniques, and validated antibodies. Before that, they worked as a Neuroscience Consultant at Tautologics from 2013 to 2015. Linda also worked as a Postdoctoral Researcher at Karolinska Institutet from 2008 to 2010, where they received an employment grant from the Swedish Research Council. Their research focused on the modulation of WNT signaling and its role in stem cell differentiation. Linda conducted extensive analysis of commercially available WNT3a preparations and discovered inconsistencies in their signaling capabilities.

Linda Adlerz completed their Master's degree in Natural Sciences at Stockholm University from 1995 to 1999. Linda later pursued a Doctor of Philosophy (PhD) degree in Neurochemistry & Molecular Neurobiology at the same university from 1999 to 2007. In 2015 and 2016, they attended Uppsala University and obtained a Licentiate degree in Biomedical Scientist.